Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with ...

Survey reveals severe impact of Good Days underfunding on retina practices, with many patients experiencing vision loss due ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology celebrates 50 years of groundbreaking innovations, highlighting anti-VEGF therapies, OCT imaging, and future ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

TearCare is associated with greater health utility over time but also resulted in significant cost savings compared with CsA ...

Nicox and Kowa entered into an agreemen in February 2024, in which Kowa was granted exclusive Japanese rights to develop and ...

Raytone Biotech has successfully treated the first patient in its clinical trial of RTP-008 for the treatment of dry eye ...

FDA approval was based on data from phase 3 trials showing significant tear production increase as early as day 1.

Genentech's Portal study shows Susvimo maintains vision and retinal drying in wet AMD patients over five years with biannual ...